Elizabeth Franklin

Elizabeth Franklin, PhD, MSW


Elizabeth Franklin, PhD, MSW, is Executive Director of the Cancer Policy Institute (CPI) where she is responsible for all aspects of the CPI including legislative, regulatory, policy, and research priorities as well as operations, fundraising, and management. Elizabeth was formerly Director of Policy and Engagement at the George Washington University Cancer Institute where she worked at both the macro level, developing and implementing the Institute’s policy agenda, and at the micro level, working with the patient-centered care team to ensure that all patients had access to high-quality, timely cancer care. Previously, Elizabeth was Senior Director of Policy and Advocacy with the Prevent Cancer Foundation as well as Special Assistant to the Chief Executive Officer at the headquarters of the National Association of Social Workers.

Elizabeth is a recognized author and speaker. Her articles have appeared in peer-reviewed journals such as the Journal of Cancer Education, Journal of Patient Experience, Journal of Clinical Pathways, Health and Social Work, and Value in Health. She has co-authored two books on non-profit leadership and co-edited two social work texts. In addition, she is a member of various organizations and coalitions, including the Association of Oncology Social Work (where she serves on the advocacy committee), Academy of Oncology Nurse and Patient Navigators (where she serves on the Leadership Council and as Chair of the Policy and Advocacy Committee), and the Alliance for Quality Psychosocial Cancer Care (where she serves as co-chair). 

Elizabeth earned her doctorate at the University of Maryland School of Social Work, where she focused her dissertation on the ways in which patients define value in the cancer care system and how those definitions can be incorporated into public policy and clinical practice. Elizabeth obtained her Masters Degree in Social Work from the University of Illinois at Chicago and her Bachelors Degree in Social Work from the University of Kentucky.

Blog Posts

Blood samples
Read December 15, 2020

Cancer Screening and Detection Innovation: What It Could Mean for Patients

Since the signing of the National Cancer Act in 1971, scientific and medical progress has resulted in extraordinary advancements in our ability to treat cancer. However, equally as important as treatment advances is our ability to detect cancer at the earliest stages, when the chance of surviving for at least five years is high.
Read June 25, 2020

What Cancer Patients, Survivors and Caregivers Need to Know about the Coronavirus

For many cancer patients and survivors with compromised immune systems, the reporting on this public health emergency may likely be source of anxiety. At a time when information is coming at us at a rapid pace, we are putting resources for you here, in one place. Read on to view a list of the resources we have and the actions CSC are taking to provide support to individuals affected by cancer.
Read December 14, 2018

Changes Proposed to Prescription Drug Commercials

In May of 2018, the Trump Administration committed to lowering the costs of prescription drugs and out-of-pocket spending for patients. One of the ways in which the Administration suggested meeting this goal was by changing the information available to consumers in television ads that market medications, which lead to a new rule that would require pharmaceutical companies to disclose the “list price” of drugs.